Kochurani K Johnson, Pramod Koshy, Chantal Kopecky, Michelle Devadason, Joanna Biazik, Xiaoran Zheng, Yue Jiang, Xiaochun Wang, Yiling Liu, Jeff Holst, Jia-Lin Yang, Kristopher A Kilian, Charles C Sorrell
The therapeutic effectiveness of anticancer drugs, including nanomedicines, can be enhanced with active receptor-targeting strategies. Epidermal growth factor receptor (EGFR) is an important cancer biomarker, constitutively expressed in sarcoma patients of different histological types. The present work reports materials and in vitro biomedical analyses of silanized (passive delivery) and/or EGF-functionalized (active delivery) ceria nanorods exhibiting highly defective catalytically active surfaces. The EGFR-targeting efficiency of nanoceria was confirmed by receptor-binding studies...
December 12, 2023: Journal of Biomedical Materials Research. Part A